Drug Profile
Filgrastim biobetter - VitaPharm
Alternative Names: G-CSF biobetter - VitaPharmLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Vitapharm Technology Development
- Class Biobetters; Granulocyte colony-stimulating factors
- Mechanism of Action Granulocyte stimulants; Haematopoiesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Discontinued Neutropenia
Most Recent Events
- 06 Sep 2017 Discontinued - Preclinical for Neutropenia in China (Sublingual)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Neutropenia in China (Sublingual, Tablet)